Emerging diagnostic technologies are key in combating antimicrobial resistance, presenting significant market opportunities. Six major pathogen areas are ripe for advancement, with over 30 companies ...

The Indian government addresses the growing antibiotic resistance crisis, blaming non-prescription use and outlining measures ...

By Vijay Kumar Malesu Why mismatched resistance thresholds between CLSI and EUCAST could be masking the true scale of ...

The Indian government is addressing the rising issue of antibiotic resistance by enforcing prescription regulations and ...

Neurothera Labs Inc. (TSXV: NTLX) ("Neurothera" or the "Company"), a clinical-stage biotech company and a majority-owned ...

(Nasdaq: SPRC) ("Company” or "SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a ...

Antimicrobial resistance (AMR) in clinically relevant bacterial pathogens represents a major and growing challenge to ...

Extensive use of synthetic fertilisers has degraded soils by reducing microbial diversity, allowing resistant organisms to ...

Discover how Listeria bacteria communicate to develop antibiotic resistance and the implications for future drug development.

On February 2, 2026, SciSparc Ltd. reported that its approximately 75%-owned subsidiary NeuroThera Labs Inc. has been granted a new U.S. patent covering proprietary combinations of established ...

A novel multi-task XGBoost model shows robust overall performance in predicting antimicrobial resistance in common gram-negative pathogens.

Bulgaria has launched a new four-year AMR national plan to achieve an 18% reduction in total antibiotic use - prescription enforcement and hospital oversight are central dynamics ...